1. Tumor pyruvate kinase M2 modulators: a comprehensive account of activators and inhibitors as anticancer agents
   Bhagyashri Rathod et al, 2021, RSC Medicinal Chemistry CrossRef
2. Proton pump inhibitors enhance chemosensitivity, promote apoptosis, and suppress migration of breast cancer cells
   Worood G. Ihraiz et al, 2020, Acta Pharmaceutica CrossRef
3. Drug Repurposing in Gastric Cancer: Current Status and Future Perspectives
   Marina Leite et al, 2023, Hereditary Gastric and Breast Cancer Syndrome CrossRef
4. PKM2–c-Myc–Survivin Cascade Regulates the Cell Proliferation, Migration, and Tamoxifen Resistance in Breast Cancer
   Pian Yu et al, 2020, Frontiers in Pharmacology CrossRef
5. Comparative randomized trial evaluating the effect of proton pump inhibitor versus histamine 2 receptor antagonist as an adjuvant therapy in diffuse large B-cell lymphoma
   Sahar K. Hegazy et al, 2021, Medical Oncology CrossRef
6. Expression and Transcriptional Regulation of Human ATP6V1A Gene in Gastric Cancers
   Pin Wang et al, 2017, Scientific Reports CrossRef
7. Repositioning of proton pump inhibitors in cancer therapy
   Zhen-Ning Lu et al, 2017, Cancer Chemotherapy and Pharmacology CrossRef
8. Identification of Gliotoxin isolated from marine fungus as a new pyruvate kinase M2 inhibitor
   Wei Tang et al, 2020, Biochemical and Biophysical Research Communications CrossRef
9. Strategies to Target Glucose Metabolism in Tumor Microenvironment on Cancer by Flavonoids
   Gang Wang et al, 2017, Nutrition and Cancer CrossRef
10. A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors
    Li-Yuan Yu et al, 2017, Advances in Therapy CrossRef
11. A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2
    Sahil Arora et al, 2022, Journal of Medicinal Chemistry CrossRef
12. Association between Proton Pump Inhibitor Use and the Risk of Female Cancers: A Nested Case-Control Study of 23 Million Individuals
    Nhi Thi Hong Nguyen et al, 2022, Cancers CrossRef
13. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in cervical cancer
    Man Guo et al, 2017, Oncotarget CrossRef
14. BAPST. A Combo of Common Use Drugs as Metabolic Therapy for Cancer: A Theoretical Proposal
    Adriana Romo-Perez et al, 2022, Current Molecular Pharmacology CrossRef
15. Proposal to Consider Chemical/Physical Microenvironment as a New Therapeutic Off-Target Approach
    Alessandro Giuliani et al, 2022, Pharmaceutics CrossRef
16. Proton pump inhibition and cancer therapeutics: A specific tumor targeting or it is a phenomenon secondary to a systemic buffering?
    Enrico Spugnini et al, 2017, Seminars in Cancer Biology CrossRef
17. Cancer metabolism control by natural products: Pyruvate kinase M2 targeting therapeutics
    Ali H. El‐Far et al, 2022, Phytotherapy Research CrossRef
18. Pantoprazole pretreatment elevates sensitivity to vincristine in drug-resistant oral epidermoid carcinoma in vitro and in vivo
    Zhen-Ning Lu et al, 2019, Biomedicine & Pharmacotherapy CrossRef
19. Coptis chinensis and dried ginger herb combination inhibits gastric tumor growth by interfering with glucose metabolism via LDHA and SLC2A1
    Min Fu et al, 2022, Journal of Ethnopharmacology CrossRef
20. Rethinking the Combination of Proton Exchanger Inhibitors in Cancer Therapy
    Elisabetta Iessi et al, 2017, Metabolites CrossRef
21. Negative Association of Proton Pump Inhibitors With Subsequent Development of Breast Cancer: A Nationwide Population‐Based Study
    Chao‐Hung Chen et al, 2019, The Journal of Clinical Pharmacology CrossRef